Significant insider selling of Ultragenyx Pharmaceutical sha...
Significant insider selling of Ultragenyx Pharmaceutical shares indicates that insiders think the stock is not cheap. Despite significant insider ownership, the prevalence of selling over buying does not inspire confidence in the company's prospects.
Insiders Could Have Profited By Holding Onto Ultragenyx Pharmaceutical Shares Despite 12% Drop
免责声明:以上信息不代表Moomoo Technologies Inc.("MTI")的任何立场,不构成与MTI及其关联公司的任何投资建议。
更多信息
评论
登录发表评论